AbbVie Inc. (ABBV): $108.28

1.39 (+1.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AbbVie Inc (ABBV) Price Targets From Analysts

Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $127 $97 $112.05 $105.9 5.81%

The Trend in the Analyst Price Target


Over the past 136 days, ABBV's average price target has gone up $4.12.

Over the past 175 days, ABBV's average upside potential has been 13.26%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-08 14 122 70 98.71 94.59 4.36%
2020-06-09 15 122 70 100.40 96.17 4.4%
2020-06-16 15 122 70 101.27 96.06 5.42%
2020-06-24 15 125 70 104.53 95.14 9.87%
2020-07-02 14 125 91 107.64 98.87 8.87%
2020-07-02 14 125 91 107.64 98.88 8.86%
2020-07-17 14 125 93 107.93 100.83 7.04%
2020-07-22 14 125 93 107.93 97.70 10.47%
2020-08-03 14 127 95 110.14 95.94 14.8%
2020-08-12 15 127 95 109.47 95.51 14.62%
2020-08-22 15 127 96 110.33 94.86 16.31%
2020-08-23 15 127 96 110.33 94.86 16.31%
2020-09-01 16 127 96 110.00 92.24 19.25%
2020-09-10 16 127 96 110.00 89.65 22.7%
2020-09-30 17 127 96 109.29 87.59 24.77%
2020-10-21 18 127 96 109.61 82.89 32.24%
2020-11-10 19 127 97 110.84 98.87 12.11%
2020-11-17 20 127 97 111.45 99.21 12.34%
2020-11-30 20 127 97 112.05 104.58 7.14%

ABBV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


list("500 - Internal server error")

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ABBV has a greater number of analysts covering the stock than 93.63% of all US stocks.
  • The average analyst price target of ABBV is higher than 93.12% of Pharmaceutical Products stocks.
  • AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 8.64% of Pharmaceutical Products stocks.
  • ABBV has a less variance in analysts' estimates than 75.38% of stocks in the large market cap category.

What is the outlook for ABBV? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7929 seconds.